Association Between Body Mass Index and Overall Survival With Immune Checkpoint Inhibitor Therapy for Advanced Non–Small Cell Lung Cancer

IMPORTANCE: High body mass index (BMI) is independently associated with overall survival benefit from immune checkpoint inhibitor therapy in patients with melanoma, yet whether BMI is associated with outcomes in patients with advanced non–small cell lung cancer treated with atezolizumab remains unkn...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:JAMA Oncol
मुख्य लेखकों: Kichenadasse, Ganessan, Miners, John O., Mangoni, Arduino A., Rowland, Andrew, Hopkins, Ashley M., Sorich, Michael J.
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: American Medical Association 2019
विषय:
Original Investigation
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC6990855/
https://ncbi.nlm.nih.gov/pubmed/31876896
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaoncol.2019.5241
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन